Parkman Healthcare Partners’s Harvard Bioscience HBIO Stock Holding History

Parkman Healthcare Partners’s Portfolio HBIO Stock Details HBIO Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$782K	Sell
2022 Q2	$1.27M	Sell
2022 Q1	$3.94M	Buy
2021 Q4	$3.79M	Buy
2021 Q3	$3.32M	Buy
2021 Q2	$3.35M	Buy